BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 14, 2003
View Archived Issues
New antidiabetic agents discovered at Toray
Read More
Antibacterial PDF inhibitors prepared and tested at Senju
Read More
Novel 5-HT4 ligands and their use in gastrointestinal disorders
Read More
BMS and Pharmacopeia jointly report new p38 kinase inhibitors
Read More
Abbott claims selective dopamine D3 modulators for use in psychoses and other disorders
Read More
Wyeth researchers identify new EAAT2 inhibitors with potential in schizophrenia
Read More
New COX-2 inhibitors covered by Pfizer patents
Read More
Basiliximab immunoprophylaxis in the prevention of acute rejection after renal transplantation
Read More
Liposomal doxorubicin combined with IL-12 synergistic in HIV-associated KS
Read More
Clinical safety and pharmacokinetics of UK-427857 in healthy volunteers
Read More
Good safety profile of the IL-2 agonist Bay-50-4798 in cynomolgus monkeys
Read More
Viral load reduction with tipranavir/ritonavir related to trough tipranavir plasma levels
Read More
diaDexus licenses rights to testisin cancer target
Read More
Telik and Vanderbilt-Ingram Cancer Center sign agreement for cancer drug discovery
Read More
Ribozyme to secure financing to support development of RNAi therapeutics
Read More
Bayer seeks expansion of aspirin labeling to include prevention of first heart attack
Read More
Renovis awarded grant to support psychiatric drug discovery
Read More
Synaptic shareholders approve merger with Lundbeck
Read More
Altus and Dr. Falk form alliance to develop TheraCLEC in Europe
Read More
BCY LifeSciences updates status of phase II DCF-987 trial in cystic fibrosis
Read More
Avanir generates antibody to neutralize anthrax toxin
Read More
AlgoRx acquires rights to novel antimigraine therapy
Read More
Effexor XR approved for social anxiety disorder
Read More
Targeted intracellular drug delivery demonstrated by Cyclosert
Read More
Novel vitamin D analogue with dissociation between immunosuppressive and hypercalcemic effects
Read More
Benzophenone NNRTIs characterized in vitro at GSK
Read More
Ro-033-4649 holds promise for protease inhibitor-resistant HIV infection
Read More